Norway
GE HealthCare concludes patient enrolment in MRI contrast agent trial
The macrocyclic, extra-cellular and manganese-based contrast agent is claimed to help improve signal intensity during MRI scans.
The macrocyclic, extra-cellular and manganese-based contrast agent is claimed to help improve signal intensity during MRI scans.